pioglitazone and metformin hydrochloride · Tablet, Film Coated

What changed in the last 90 days

Every detected change for pioglitazone and metformin hydrochloride, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Biguanide, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

• empagliflozin, linagliptin, metformin hydrochloride· 1 maker
• empagliflozin, metformin hydrochloride· 1 maker
• metformin hydrochloride tablets· 1 maker
• pioglitazole and metformin hydrochloride· 1 maker
• pioglitazone hcl and metformin hcl· 1 maker
• saxagliptin and metformin· 1 maker
• saxagliptin and metformin hydrochloride· 1 maker
• canagliflozin and metformin hydrochloride· 2 makers
• empagliflozin and metformin hydrochloride· 2 makers
• ertugliflozin and metformin hydrochloride· 2 makers
• glipizide and metformin hcl· 3 makers
• metformin hydrochloride extended-release tablets· 3 makers

Common questions

Is Pioglitazone and metformin hydrochloride in shortage right now?

No. FDA does not currently list Pioglitazone and metformin hydrochloride in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.

Who makes Pioglitazone and metformin hydrochloride?

3 companies have marketed Pioglitazone and metformin hydrochloride in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.

What does Pioglitazone and metformin hydrochloride cost?

The typical pharmacy pays about $0.2985 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.